회사 소개
- 법인명: Guangdong Raffles PharmaTech Co Ltd
- 등록 국가: China
- 주소: No 3, Binhai 10th Road North, Shihua Dadao Middle, Daya Bay, Huizhou, Guangdong
- 직원 수: 250 - 499
설명:
Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceutical ingredients and intermediates. We are specialized in applying organic catalysts into the process development to lower cost, and to provide cost-effective product and service to customers. With our strong R&D capability and our proprietary organic catalysts, we provide low cost and high quality active pharmaceutical ingredients and intermediates to pharmaceutical companies. We also provide world standard process development, custom synthesis and manufacturing service.
사업 활동
원료의약품(API)
제조업체
계약 및 아웃소싱 서비스
제조업체
제약용 화학물질
제조업체
임상시험수탁기관 서비스(CRO)
제조업체
바이오의약품 서비스
제조업체
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
주요 제품/서비스
- 제약용 화학물질: (2R,6R)-2,6-diphenyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2R)-2-Piperidine Methanamine, (3S,11aR)-N-(2,4-difluorobenzyl)-6-methoxy-3-methyl-5,7, (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, 1,5,7-Triazabicyclo[4.4.0]dec-5-ene, 1,4,6-Triazabicyclo[3.3.0]oct-4-ene, (4S,5S)-1H-lmidazolium,2- [[(4S,5S)-1,3-dimiethyl-4,5, (S)-a-(Phenylmethyl)-1-pyrrolidinethanamine, (R)-VAPOL HYDROGENPHOSPHATE, (8a,9R)- 10,11-dihydro-Cinchonan-6',9-diol, (9S)-9-(9-phenanthrenyloxy)-Cinchonan-6'-ol, (S)-(–)-a,a-Diphenyl-2-pyrrolidinemethanol trimethylsilyl ether, 2-(diphenylphosphino)-N-(pyridin-2-ylmethyl)ethanamine, (S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H- [1,2,4], (5aR,10bS)-(+)-5a,10b-Dihydro-2-(pentafluorophenyl, (5aS, 10bR)-(-)-5a,10b-Dihydro-2-(pentafluorophe, 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, (S)-5-benzyl-2-phenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c], (S)-2-[[(1R,2R)-2-AMINOCYCLOHEXYL]THIOUREIDO] -N-BENZYL-N,3,3-TRIMETHYLBUTANAMIDE, (2S)-2-[[[[3,5-Bis(trifluoromethyl) phenyl]amino], 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1R,2R)-2-(dimethylamino)cyclohexyl]thiourea, (2S)-2-amino-N,3,3-trimethyl-N-(phenylmethyl)-ButaN/Amide, (S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl) -3-((1R,2R)-2-(dipropylamino)cyclohexyl)thiour, 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1S,2S)-2-(dimethylamino)cyclohexyl]thiourea, (S)-2-[[(1R,2R)-2-[[[3,5-Bis(tert-butyl)-2-hydroxyphenyl] methylene]amino]cyclohexyl]thioureido], 2-Propanesulfinamide, N-[(1R,2R)-2-[[[[3,5-bis(trifluoromethyl)phenyl]amino] carbonyl]amino]cycloh, (2S)-3,3-DIMETHYL-2-[[(1R,2R)-2-(2-METHYL-5-PHENYL-1-PYRROLYL) CYCLOHEXYL]THIOUREIDO]-N,N-BIS(2-ISO, (R,R)-(+)-Hydrobenzoin, (2S)-2-Piperidine Methanamine, (2S,3S,4S,5R,6R)-6-bromotetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate, (3S)-3-Thiophenamine, tetrahydro-, 1,1-dioxide, hydrochloride (1:1), (2S,3R)-2-hydroxy-3-(naphthalen-2-ylmethyl)succinic acid1, (R)-2-((S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl) -3-(naphthalen-2-yl)propanoic acid, (S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1-naphthalenone, 1,4-difluoroanthraquinone
당사 제품 & 서비스
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
인증
GMP
ISO
증거
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기